Interactions of cocaine with nimodipine: A brief report

American Journal on Addictions

Volumn 8, Issue 1, 1999, Pages 77-81

  Kosten, Thomas R ^a,b   Woods, Scott W ^a   Rosen, Marc I ^a,b   Pearsall, H Rowland ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COCAINE; NIMODIPINE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG MIXTURE; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; CALCIUM CHANNEL BLOCKERS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NIMODIPINE;

EID: 0032976878     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/105504999306117     Document Type: Article

References (18)

1. Kuzmin A, Zvartau E, Gessa GL, et al. Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice. Pharmacol-Biochem-Behav. 1992; 41(3):497-500.
2. Muntaner C, Kumor KM, Nagoshi C, et al. Effects of nifedipine pr on subjective and cardiovascular responses to intravenous cocaine in humans. Psychopharmacology-Berl. 1991; 105(1):37-41.
3. Pani L, Kuzmin A, Diana M, et al. Calcium receptor antagonists modify cocaine effects in the central nervous system differently. Eur J Pharmacol. 1990; 190(1-2):217-221.
4. Pani L, Kuzmin A, Martellotta MC, et al. The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine. Brain Res Bull. 1991; 26(3):445-447.
5. Schechter MD. Cocaine discrimination is attenuated by isradipine and CGS 10746B. Pharmacology, Biochem & Beh. 1993; 44(3):661-664.
6. Rowbotham MC, Hooker WD, Mendelson J, et al. Cocaine-calcium channel antagonist interactions (abstract). Psychopharmacology-Berl. 1987; 93(2):152-154.
7. Reid LD, Pabello NG, Cramer CM, et al. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse. Life Sci. 1997; 60(8):PL119-126.
8. Billman GE. Effect of calcium channel antagonists on cocaine-induced malignant arrhythmias: Protection against ventricular fibrillation. J Pharmacol Exp Ther. 1993; 266(1):407-416.
9. Freedman DD, Waters DD. "Second generation" dihydropyridine calcium antagonists: greater vascular selectivity and some unique applications. Drugs. 1987; 34:578-598.
10. Rosse RB, Alim TN, Fay-McCarthy M, et al. Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence. Clin Neuropharmacology. 1994; 17(4):348-358.
11. Pitts WR, Lange RA, Cigarroa JE, et al. Cocaine-induced myocardial ischemia and infarction: Pathophysiology, recognition, and management. Prog Cardiovasc Dis. 1997; 40(1):65-76.
12. Boja JW, Kopajtic TA. Ion channel inhibitors may function as potential modulators of cocaine binding. Neuropharmacology. 1993; 32(3):229-234.
13. Calcagnetti DJ, Keck BJ, Quatrella LA, et al. Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeutics. Life Sci. 1995; 56(7):475-483.
14. Biala G, Langwinski R. Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol, and cocaine as measured by place conditioning. J Physiol Pharmacol. 1996; 47(3):497-502.
15. Kosten TR. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug and Alcohol Dependence. 1998; 49:133-144.
16. Kosten TR, McCance Katz E. A review of pharmacotherapies for substance abuse. Am J Addictions. 1996; 5(1):58-65.
17. Murray GD, Teasdale GM, Schmitz H. Nimodipine in traumatic subarachnoid haemorrhage: A reanalysis of the HIT I and HIT II trials. Acta Neurochirurgica. 1996; 138(10):1163-1167.
18. Harders A, Kakarieka A, Braakman R. Traumatic subarachnoid hemorrhage and its treatment with nimodipine. J Neurosurgery. 1996; 85(1):82-89.